Page 2 - Biological E News Today

Hyderabad-based Mahima Datla and family became richer by Rs 1,000 crore from the previous year when her net worth was Rs 7,700 crore in the 2021 IIFL Wealth Hurun India Rich List.

The state government has arranged 5 lakh doses of Corbevax, manufactured by Hyderabad-based Biological E. Hyderabad, April 19 (IANS) The Telangana government on Wednesday commenced administering booster doses as a precautionary measure in view of increase in Covid-19 cases.

Reifman opens up a plethora of relevant issues like the strategic significance and growing strength of the Indo-US relationship

Hyderabad-based pharmaceutical and vaccine manufacturer Biological E Limited (BE), on Friday announced that its 14-valent paediatric Pneumococcal Conjugate Vaccine has received approval for manufacture and commercialisation in India.

The vaccine is found safe & immunogenic in 5-18 age group

Indian Immunologicals Ltd (IIL) on Monday announced that it will invest Rs 700 crore to set up a new animal vaccine manufacturing facility in Genome Valley, Hyderabad.

The vaccine is an investigational 14-valent pediatric pneumococcal vaccine named as polysaccharide conjugate vaccine (PCV14) against Streptococcus pneumoniae infection in single dose and multi dose presentations.

The price of Corbevax for private COVID-19 vaccination centres is Rs 250, inclusive of the Goods and Sales tax. For the end-user, the price of the vaccine is Rs 400, including taxes and administrative charges.

Corbevax was also approved by the Union Health Ministry as a heterologous COVID-19 booster dose under emergency use authorization for individuals aged 18 years and above after 6 months of administration of primary vaccination (two doses) of Covaxin or Covishield, the company said.

 This is for the first time that a booster dose that is different from the one used for primary vaccination against Covid has been allowed in the country.